OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE)
Rosalba Leuci, Leonardo Brunetti, Antonio Laghezza, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 958-958
Open Access | Times Cited: 11
Rosalba Leuci, Leonardo Brunetti, Antonio Laghezza, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 958-958
Open Access | Times Cited: 11
Showing 11 citing articles:
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1560-1560
Open Access | Times Cited: 42
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1560-1560
Open Access | Times Cited: 42
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease
Leonardo Brunetti, Rosalba Leuci, Antonio Carrieri, et al.
European Journal of Medicinal Chemistry (2022) Vol. 237, pp. 114358-114358
Closed Access | Times Cited: 27
Leonardo Brunetti, Rosalba Leuci, Antonio Carrieri, et al.
European Journal of Medicinal Chemistry (2022) Vol. 237, pp. 114358-114358
Closed Access | Times Cited: 27
Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases
Antonio Carrieri, Alexia Barbarossa, Modesto de Candia, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 110, pp. 117829-117829
Open Access | Times Cited: 2
Antonio Carrieri, Alexia Barbarossa, Modesto de Candia, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 110, pp. 117829-117829
Open Access | Times Cited: 2
Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease
Alessia Carocci, Alexia Barbarossa, Rosalba Leuci, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1631-1631
Open Access | Times Cited: 13
Alessia Carocci, Alexia Barbarossa, Rosalba Leuci, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1631-1631
Open Access | Times Cited: 13
Natural phenol carbamates: Selective BuChE/FAAH dual inhibitors show neuroprotection in an Alzheimer’s disease mouse model
Kuanrong Rong, Ziyun Li, Jinhui Wu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117003-117003
Closed Access | Times Cited: 1
Kuanrong Rong, Ziyun Li, Jinhui Wu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117003-117003
Closed Access | Times Cited: 1
A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition
Antonio Laghezza, Carmen Cerchia, Massimo Genovese, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 5, pp. 3566-3587
Closed Access | Times Cited: 3
Antonio Laghezza, Carmen Cerchia, Massimo Genovese, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 5, pp. 3566-3587
Closed Access | Times Cited: 3
Historic recurrences in medicinal chemistry: nature-inspired structures as a new opportunity for novel multi-target anti-Alzheimer’s drugs
Luca Piemontese
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2671-2672
Open Access | Times Cited: 3
Luca Piemontese
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2671-2672
Open Access | Times Cited: 3
In silico Strategy: A Promising Implement in the Development of Multitarget Drugs against Neurodegenerative Diseases
Purusottam Banjare, Balaji Wamanrao Matore, Anjali Murmu, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 29, pp. 2765-2791
Closed Access | Times Cited: 3
Purusottam Banjare, Balaji Wamanrao Matore, Anjali Murmu, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 29, pp. 2765-2791
Closed Access | Times Cited: 3
Recent Advancements in the Treatment of Alzheimer’s Disease: A Multitarget-directed Ligand Approach
Sumit Kumar, Amol T. Mahajan, Ramesh Ambatwar, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 37, pp. 6032-6062
Closed Access | Times Cited: 2
Sumit Kumar, Amol T. Mahajan, Ramesh Ambatwar, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 37, pp. 6032-6062
Closed Access | Times Cited: 2
N-(2-(Benzylamino)ethyl)-4-(naphthalene-1-sulfonamido)benzamide
Rosalba Leuci, Fulvio Loiodice, Luca Piemontese
Molbank (2024) Vol. 2024, Iss. 3, pp. M1856-M1856
Open Access
Rosalba Leuci, Fulvio Loiodice, Luca Piemontese
Molbank (2024) Vol. 2024, Iss. 3, pp. M1856-M1856
Open Access
Role of Target Fishing in Discovery of Novel Anti-Alzheimer’s Agents: In Silico Applications
Anjali Murmu, Balaji Wamanrao Matore, Purusottam Banjare, et al.
(2023), pp. 245-284
Closed Access | Times Cited: 1
Anjali Murmu, Balaji Wamanrao Matore, Purusottam Banjare, et al.
(2023), pp. 245-284
Closed Access | Times Cited: 1
